194 related articles for article (PubMed ID: 34827566)
1. Aspirin-Based Organoiron Dendrimers as Promising Anti-Inflammatory, Anticancer, and Antimicrobial Drugs.
Abd-El-Aziz AS; Benaaisha MR; Abdelghani AA; Bissessur R; Abdel-Rahman LH; Fayez AM; El-Ezz DA
Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827566
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological Evaluation of Novel Organoiron Dendrimers as Antimicrobial and Anti-Inflammatory Agents.
Abd-El-Aziz AS; Abdelghani AA; El-Ghezlani EG; Abou El-Ezz D; Abdel-Rahman LH
Macromol Biosci; 2021 Jan; 21(1):e2000242. PubMed ID: 33063474
[TBL] [Abstract][Full Text] [Related]
3. Janus Dendrimers as Nanocarriers of Ibuprofen, Chlorambucil and their Anticancer Activity.
Pedro-Hernández LD; Barajas-Mendoza I; Castillo-Rodríguez IO; Klimova E; Ramírez-Ápan T; Martínez-García M
Pharm Nanotechnol; 2024; 12(3):276-287. PubMed ID: 37592778
[TBL] [Abstract][Full Text] [Related]
4. Design of Organoiron Dendrimers Containing Paracetamol for Enhanced Antibacterial Efficacy.
Abd-El-Aziz AS; El-Ghezlani EG; Abdelghani AA
Molecules; 2020 Oct; 25(19):. PubMed ID: 33023084
[TBL] [Abstract][Full Text] [Related]
5. Dendrimer as a promising nanocarrier for the delivery of doxorubicin as an anticancer therapeutics.
Singh V; Kesharwani P
J Biomater Sci Polym Ed; 2021 Oct; 32(14):1882-1909. PubMed ID: 34078252
[TBL] [Abstract][Full Text] [Related]
6. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S
Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613
[TBL] [Abstract][Full Text] [Related]
7. Complexes of Indomethacin with 4-Carbomethoxy-pyrrolidone PAMAM Dendrimers Show Improved Anti-inflammatory Properties and Temperature-Dependent Binding and Release Profile.
Ficker M; Theeuwen MJM; Janaszewska A; Gorzkiewicz M; Svenningsen SW; Klajnert-Maculewicz B; Christensen JB
Mol Pharm; 2018 Aug; 15(8):3573-3582. PubMed ID: 30011214
[TBL] [Abstract][Full Text] [Related]
8. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release.
Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH
Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661
[TBL] [Abstract][Full Text] [Related]
9. Biotin Transport-Targeting Polysaccharide-Modified PAMAM G3 Dendrimer as System Delivering α-Mangostin into Cancer Cells and
Markowicz J; Uram Ł; Wołowiec S; Rode W
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884739
[TBL] [Abstract][Full Text] [Related]
10. Dendrimer encapsulated and conjugated delivery of berberine: A novel approach mitigating toxicity and improving in vivo pharmacokinetics.
Gupta L; Sharma AK; Gothwal A; Khan MS; Khinchi MP; Qayum A; Singh SK; Gupta U
Int J Pharm; 2017 Aug; 528(1-2):88-99. PubMed ID: 28533175
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin.
Kirkpatrick GJ; Plumb JA; Sutcliffe OB; Flint DJ; Wheate NJ
J Inorg Biochem; 2011 Sep; 105(9):1115-22. PubMed ID: 21704583
[TBL] [Abstract][Full Text] [Related]
12. Dendrimer toxicity: Let's meet the challenge.
Jain K; Kesharwani P; Gupta U; Jain NK
Int J Pharm; 2010 Jul; 394(1-2):122-42. PubMed ID: 20433913
[TBL] [Abstract][Full Text] [Related]
13. Poly(amidoamine) Dendrimers as Nanocarriers for 5-Fluorouracil: Effectiveness of Complex Formation and Cytotoxicity Studies.
Szota M; Reczyńska-Kolman K; Pamuła E; Michel O; Kulbacka J; Jachimska B
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681827
[TBL] [Abstract][Full Text] [Related]
14. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
[TBL] [Abstract][Full Text] [Related]
15. The Therapeutic Efficacy of Dendrimer and Micelle Formulations for Breast Cancer Treatment.
Alven S; Aderibigbe BA
Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33333778
[TBL] [Abstract][Full Text] [Related]
16. Selenium-Platinum Coordination Dendrimers with Controlled Anti-Cancer Activity.
Li T; Smet M; Dehaen W; Xu H
ACS Appl Mater Interfaces; 2016 Feb; 8(6):3609-14. PubMed ID: 26390019
[TBL] [Abstract][Full Text] [Related]
17. Cell death-inducing properties of selected dendrimers against different breast cancer and leukemia cell lines.
Baecker D; Kapp T; Schumacher P; Gust R; Kircher B
Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000209. PubMed ID: 32780524
[TBL] [Abstract][Full Text] [Related]
18. Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer.
Kesharwani P; Tekade RK; Jain NK
Biomaterials; 2014 Jul; 35(21):5539-48. PubMed ID: 24731713
[TBL] [Abstract][Full Text] [Related]
19. Targeting Breast Cancer Cells with G4 PAMAM Dendrimers and Valproic Acid Derivative Complexes.
Muñoz AM; Fragoso-Vázquez MJ; Martel BP; Chávez-Blanco A; Dueñas-González A; R García-Sánchez J; Bello M; Romero-Castro A; Correa-Basurto J
Anticancer Agents Med Chem; 2020; 20(15):1857-1872. PubMed ID: 32324521
[TBL] [Abstract][Full Text] [Related]
20. Preclinical studies of dendrimer prodrugs.
Kojima C
Expert Opin Drug Metab Toxicol; 2015; 11(8):1303-15. PubMed ID: 26028253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
